Tjg. Brooks et Rj. Phillpotts, Interferon-alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes, ANTIVIR RES, 41(1), 1999, pp. 57-64
In common with other flaviviruses, there is no specific therapy for St Loui
s encephalitis (SLE) virus infections. A number of cases have occurred wher
e infection may have been acquired by the aerosol route in laboratory accid
ents. The recombinant human interferon hybrids IFN-alpha A/D (Roche Laborat
ories) and IFN-alpha BID (Ciba-Geigy) have activity in murine models. Given
for several days around the time of exposure to the virus or shortly after
: these compounds reduce the mortality from SLE virus administered to mice
subcutaneously by up to 70%. In an aerosol model of SLE disease, the mortal
ity was reduced to 30-50% compared to 100% in controls, depending on the ch
allenge level of virus. These results suggest that interferon-alpha could b
e used to reduce the mortality from SLE infection after known exposure to t
he virus. (C) 1999 Elsevier Science B.V. All rights reserved.